Enhabit, Inc. (EHAB)
(Delayed Data from NYSE)
$8.21 USD
+0.19 (2.37%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $8.20 -0.01 (-0.12%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.21 USD
+0.19 (2.37%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $8.20 -0.01 (-0.12%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth A Momentum A VGM
Zacks News
Enhabit (EHAB) Q2 Earnings Surpass Estimates
by Zacks Equity Research
Enhabit (EHAB) delivered earnings and revenue surprises of 16.67% and 2.03%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Here Is Why Bargain Hunters Would Love Fast-paced Mover Enhabit (EHAB)
by Zacks Equity Research
Enhabit (EHAB) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Enhabit (EHAB) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Enhabit (EHAB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Earnings Preview: Viatris (VTRS) Q2 Earnings Expected to Decline
by Zacks Equity Research
Viatris (VTRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Enhabit (EHAB) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Enhabit (EHAB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Teladoc (TDOC) Q2 Earnings Navigate BetterHelp Profit Woes?
by Zacks Equity Research
Teladoc's (TDOC) second-quarter results are likely to reflect lower advertising and marketing expenses.
Revvity (RVTY) Tops Q2 Earnings Estimates
by Zacks Equity Research
Revvity (RVTY) delivered earnings and revenue surprises of 7.96% and 0.39%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Why Enhabit (EHAB) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Enhabit (EHAB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Elevance Health (ELV) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Elevance Health (ELV) delivered earnings and revenue surprises of 1.30% and 0.54%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Enhabit (EHAB) Beats Q1 Earnings Estimates
by Zacks Equity Research
Enhabit (EHAB) delivered earnings and revenue surprises of 40% and 2.18%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Surgery Partners (SGRY) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Surgery Partners (SGRY) delivered earnings and revenue surprises of 42.86% and 1.38%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Enhabit (EHAB) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Enhabit (EHAB) delivered earnings and revenue surprises of -25% and 1.53%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Doximity (DOCS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Doximity (DOCS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Enhabit (EHAB) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Enhabit (EHAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Icon PLC (ICLR) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Icon PLC (ICLR) delivered earnings and revenue surprises of 0.61% and 0.29%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Enhabit (EHAB) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Enhabit (EHAB) delivered earnings and revenue surprises of -71.43% and 3.38%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Embecta Corp. (EMBC) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Embecta Corp. (EMBC) delivered earnings and revenue surprises of 50% and 4.06%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Why Is Encompass Health (EHC) Up 7.5% Despite Q3 Earnings Miss?
by Zacks Equity Research
Encompass Health (EHC) intends to open 6-10 de novo locations and increase the bed count by 100-150 per annum, till 2026.
Encompass (EHC) Opens Its 4th Inpatient Rehab Unit in Illinois
by Zacks Equity Research
Encompass Health's (EHC) Quad Cities Rehabilitation Institute has 40 beds and serves patients who are recovering from enervating and complex illnesses and injuries.
Encompass Health (EHC) to Build New Rehab Unit in Missouri
by Zacks Equity Research
Encompass Health (EHC) and BJC HealthCare's new rehabilitation hospital is expected to come online in 2024.